Sutter Health at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

Sutter Health takes part in 4 sessions at CTAD 2026 in Boston. Its program centres on anti-amyloid treatment in a large integrated health system, from real-world experience to safe access in general neurology. Its work also covers donanemab with modified titration and a biobank registry for TDP-43 encephalopathy.

Organization	CTAD 2026 Attendance
Sutter Health Sacramento, California
sutterhealth.org Hospitals & health systems Northern California health system; its Ray Dolby Brain Health Center diagnoses, treats and researches memory disorders.	Poster Wed Nov 18 7:15am–5:30pm Establishing a Biobank Registry for Limbic-predominant Age-related TDP-43 Encephalopathy at Sutter Health (P301) Real-world data and access Talk Wed Nov 18 4:30pm Characterization of US Real-World Patients Receiving Donanemab with Modified Titration Using the NeuroDiscovery AI Database and the ALZ-NET Registry Anti-amyloid and anti-tau therapies · Real-world data and access Poster Thu Nov 19 7:15am–5:00pm Real-world Experience of Amyloid-Targeting Therapies at Sutter Health - a Large Integrated Healthcare System (P471) Anti-amyloid and anti-tau therapies · Real-world data and access Poster Thu Nov 19 7:15am–5:00pm A Multidisciplinary Model to Facilitate Safe Access to Amyloid-Targeting Therapies in General Neurology Across the Sutter Health System (P472) Real-world data and access · Anti-amyloid and anti-tau therapies

Organization

CTAD 2026 Attendance

Sutter Health

Sacramento, California

sutterhealth.org

Hospitals & health systems

Northern California health system; its Ray Dolby Brain Health Center diagnoses, treats and researches memory disorders.

Poster

Wed Nov 18
7:15am–5:30pm

Establishing a Biobank Registry for Limbic-predominant Age-related TDP-43 Encephalopathy at Sutter Health (P301)

Real-world data and access

Talk

Wed Nov 18
4:30pm

Characterization of US Real-World Patients Receiving Donanemab with Modified Titration Using the NeuroDiscovery AI Database and the ALZ-NET Registry

Anti-amyloid and anti-tau therapies · Real-world data and access

Poster

Thu Nov 19
7:15am–5:00pm

Real-world Experience of Amyloid-Targeting Therapies at Sutter Health - a Large Integrated Healthcare System (P471)

Anti-amyloid and anti-tau therapies · Real-world data and access

Poster

Thu Nov 19
7:15am–5:00pm

A Multidisciplinary Model to Facilitate Safe Access to Amyloid-Targeting Therapies in General Neurology Across the Sutter Health System (P472)

Real-world data and access · Anti-amyloid and anti-tau therapies

Instantly find 20 buyers from Sutter Health

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction